Hubei vs. Covid-19: An In-Depth Focus on Expected Pharmaceutical Supply Chain Disruptions & Drug Shortages
Make no mistake. While outwardly showing signs of restrain, pharmaceutical companies have spent substantial financial and strategic resources on risk-assessments over how the coronavirus epidemic